Final decisions to amend the current Poisons Standard in relation to palmitoylethanolamide and glycopyrronium

This web publication constitutes a notice for the purposes of regulations 42ZCZS of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS, this notice publishes:

• Decisions made by a delegate of the Secretary pursuant to regulations 42ZCZR
• reasons for that final decision
• date of effect of the decision

Glycopyrronium was considered at the ACMS #43 meeting and palmitoylethanolamide at the Joint ACMS-ACCS #37 meeting in November 2023.

Final decision and reasons

We aim to provide documents in an accessible format. If you're having problems using this document, please contact medicines.scheduling@health.gov.au.

Contents

• Notice of final decisions to amend (or not amend) the current Poisons Standard
• Final decisions on proposed amendments referred to the Advisory Committee on Medicines Scheduling (ACMS #43, November 2023)
  • Glycopyrronium
• Final decisions on proposed amendments referred to the Advisory Committees on Medicines and Chemicals Scheduling in joint session (ACMS-ACCS #35, November 2023)
  • Palmitoylethanolamide (PEA)